文献速递疼痛医学区域麻醉与超声

截肢相关疼痛与简明疼痛量表评分的最小临床重要改善:基于患者整体改善报告的回顾性分析

Smallest Clinically Meaningful Improvement in Amputation-Related Pain and Brief Pain Inventory Scores as Defined by Patient Reports of Global Improvement After Cryoneurolysis: a Retrospective Analysis of a Randomized, Controlled Clinical Trial.
PubMed 文献 · Anesth Analg · 2024-11-15

该研究基于一项多中心随机对照试验的144例下肢截肢伴幻肢痛患者数据,采用锚定法(基于PGIC)计算经皮冷冻神经溶解术后幻肢痛NRS和简明疼痛量表干扰子量表的临床重要改善阈值。结果显示小、中、大改善对应的NRS中位变化分别为1、3、4分,简明疼痛量表干扰子量表分别为16、24、34分。

要点

  • 幻肢痛NRS小、中、大改善的MCID中位值分别为1、3、4分。
  • 简明疼痛量表干扰子量表小、中、大改善中位值分别为16、24、34分。
  • 患者定义的临床重要改善与药物治疗研究结果相似。

核心结论

  • 截肢伴幻肢痛患者经皮冷冻神经溶解术后,患者报告的临床重要改善阈值与药物治疗研究相似,但简明疼痛量表干扰子量表的MCID较既往发表值略大。

研究设计与样本

  • 回顾性分析一项已发表的多中心随机对照试验数据,纳入144例下肢截肢伴幻肢痛患者。
  • 患者接受单次股神经和坐骨神经利多卡因阻滞后随机接受超声引导经皮冷冻神经溶解或假治疗。
  • 采用锚定法基于患者整体印象变化量表(PGIC)计算最小临床重要差异(MCID)。

主要发现

  • 4个月时幻肢痛NRS(0-10)小、中、大改善的中位(IQR)分别为1[1-1]、3[3-4]、4[3-6]。
  • 简明疼痛量表干扰子量表(0-70)小、中、大改善的中位(IQR)分别为16[6-18]、24[22-31]、34[22-46]。

关键数值与推荐

  • 幻肢痛NRS小改善MCID中位值为1分,中改善为3分,大改善为4分。
  • 简明疼痛量表干扰子量表小改善MCID中位值为16分,中改善为24分,大改善为34分。

临床怎么用

  • 临床解读幻肢痛治疗研究时,可参考NRS改善1分作为小但临床有意义的阈值。
  • 简明疼痛量表干扰子量表改善16分可视为小但临床有意义的阈值。

局限性

  • 研究为回顾性分析,基于单一随机对照试验数据。
  • MCID基于患者整体印象变化量表锚定法,可能存在主观偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The smallest meaningful improvement in pain scores (minimal clinically important difference [MCID]) after an analgesic intervention is essential information when both interpreting published data and designing a clinical trial. However, limited information is available for patients with chronic pain conditions, and what is published is derived from studies involving pharmacologic and psychological interventions. We here calculate these values based on data collected from 144 participants of a previously published multicenter clinical trial investigating the effects of a single treatment with percutaneous cryoneurolysis. METHODS: In the original trial, we enrolled patients with a lower-limb amputation and established phantom pain. Each received a single-injection femoral and sciatic nerve block with lidocaine and was subsequently randomized to receive either ultrasound-guided percutaneous cryoneurolysis or sham treatment at these same locations. Investigators, participants, and clinical staff were masked to treatment group assignment with the exception of the treating physician performing the cryoneurolysis, who had no subsequent participant interaction. At both baseline and 4 months (primary end point), participants rated their phantom limb pain based on a numeric rating scale (NRS) and their interference of pain on physical and emotional functioning as measured with the Brief Pain Inventory's interference subscale. They subsequently qualitatively defined the change using the 7-point ordinal Patient Global Impression of Change (PGIC). The smallest clinically meaningful improvements in phantom limb pain and Brief Pain Inventory scores were calculated using an anchor-based method based on the PGIC. RESULTS: The median (interquartile range [IQR]) phantom pain NRS (0-10) improvements at 4 months considered small, medium, and large were 1 [1-1], 3 [3-4], and 4 [3-6], respectively. The median improvements in the Brief Pain Inventory interference subscale (0-70) associated with a small, medium, and large analgesic changes were 16 [6-18], 24 [22-31], and 34 [22-46]. The proportions of patients that experienced PGIC ≥5 were 33% and 36% in the active and placebo groups, respectively. The relative risk of a patient experiencing PGIC ≥5 in the active group compared to the sham group with 95% confidence interval was 0.9 (0.6-1.4), P = .667. CONCLUSIONS: Amputees with phantom limb pain treated with percutaneous cryoneurolysis rate analgesic improvements as clinically meaningful similar to pharmacologic treatments, although their MCID for the Brief Pain Inventory was somewhat larger than previously published values. This information on patient-defined clinically meaningful improvements will facilitate interpretation of available studies and guide future trial design.

来源:Anesth Analg,查看原文。版权归原作者所有。

引用

  1. Ilfeld BM, Smith CR, Turan A, et al. Smallest Clinically Meaningful Improvement in Amputation-Related Pain and Brief Pain Inventory Scores as Defined by Patient Reports of Global Improvement After Cryoneurolysis: a Retrospective Analysis of a Randomized, Controlled Clinical Trial. Anesth Analg. 2024. PMID: 38478876. doi:10.1213/ANE.0000000000006833

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。